Literature DB >> 1605608

Characterization of four beta-lactamases produced by Staphylococcus aureus.

D J Zygmunt1, C W Stratton, D S Kernodle.   

Abstract

Staphylococcus aureus produces four types of beta-lactamase (A, B, C, and D). To investigate the effect of specific beta-lactamase type upon staphylococcal resistance, each beta-lactamase was purified to homogeneity, and the Michaelis constants (Km values) and turnover numbers (kcat values) for various penicillin and cephalosporin substrates were determined. Whereas Km values of the four beta-lactamases were comparable for penicillin G, cephalothin, and cefamandole, the type A and D enzymes exhibited greater affinity than the type B and C beta-lactamases for nitrocefin, cefazolin, and cephapirin. Conversely, the type B and C beta-lactamases exhibited greater kcat values than the type A and D enzymes against most of the cephalosporin agents, excluding nitrocefin. In contrast to earlier reports suggesting that the type B beta-lactamase is relatively inefficient in hydrolyzing penicillin G, we found only minor differences in the specific activities and kcat values of the type A, B, and C beta-lactamases. The type D beta-lactamase was distinctly less active against penicillin G, however, exhibiting only 15 to 25% of the kcat values of the other beta-lactamases. More than a 2,000-fold difference between the relative efficiencies of hydrolysis (kcat/Km) of cefazolin and cefuroxime by the type A beta-lactamase exists. This greatly exceeds the 60-fold difference in the stability of penicillin G and cefazolin with the same enzyme. Whereas the isoelectric points of the type A, B, and C beta-lactamases were similar, the value for the type D beta-lactamase was distinguishably lower (10.1 for types A, B, and C and 9.7 for type D). We conclude that marked differences in the stability of commonly used beta-lactams to hydrolysis by the staphylococcal beta-lactamases are present. This heterogeneity and the clinical implication thereof need to be considered in the antibiotic management of staphylococcal infection.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1605608      PMCID: PMC188454          DOI: 10.1128/AAC.36.2.440

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  32 in total

1.  An unusual "penicillinase plasmid" in staphylococcus aureus; evidence for its transfer under natural conditions.

Authors:  R W Lacey; V T Rosdahl
Journal:  J Med Microbiol       Date:  1974-02       Impact factor: 2.472

2.  Naturally occurring constitutive -lactamase of novel serotype in Staphylococcus aureus.

Authors:  V T Rosdahl
Journal:  J Gen Microbiol       Date:  1973-07

3.  Comparison of assay techniques for beta-lactamase activity.

Authors:  G W Ross; K V Chanter; A M Harris; S M Kirby; M J Marshall; C H O'Callaghan
Journal:  Anal Biochem       Date:  1973-07       Impact factor: 3.365

4.  Purification of penicillinase ( -lactamase) and acid phosphatase from Staphylococcus aureus in one procedure.

Authors:  W Schaeg; R Bingöl; H Blobel
Journal:  Biochim Biophys Acta       Date:  1972-05-12

5.  Inactivation of cefazolin, cephaloridine, and cephalothin by methicillin-sensitive and methicillin-resistant strains of Staphylococcus aureus.

Authors:  C Regamey; R D Libke; E R Engelking; J T Clarke; M M Kirby
Journal:  J Infect Dis       Date:  1975-03       Impact factor: 5.226

6.  Identification of beta-lactamases by analytical isoelectric focusing: correlation with bacterial taxonomy.

Authors:  M Matthew; A M Harris
Journal:  J Gen Microbiol       Date:  1976-05

7.  The use of analytical isoelectric focusing for detection and identification of beta-lactamases.

Authors:  A Mathew; A M Harris; M J Marshall; G W Ross
Journal:  J Gen Microbiol       Date:  1975-05

8.  Treatment of experimental Staphylococcus aureus endocarditis: comparison of cephalothin, cefazolin, and methicillin.

Authors:  J Carrizosa; J Santoro; D Kaye
Journal:  Antimicrob Agents Chemother       Date:  1978-01       Impact factor: 5.191

9.  Importance of beta-lactamase inactivation in treatment of experimental endocarditis caused by Staphylococcus aureus.

Authors:  P L Goldman; R G Petersdorf
Journal:  J Infect Dis       Date:  1980-03       Impact factor: 5.226

10.  Antistaphylococcal activity and beta-lactamase resistance of newer cephalosporins.

Authors:  W E Farrar; P K Gramling
Journal:  J Infect Dis       Date:  1976-06       Impact factor: 5.226

View more
  30 in total

1.  Characterization and quantitation of a novel β-lactamase gene found in a wastewater treatment facility and the surrounding coastal ecosystem.

Authors:  Miguel I Uyaguari; Erin B Fichot; Geoffrey I Scott; R Sean Norman
Journal:  Appl Environ Microbiol       Date:  2011-09-30       Impact factor: 4.792

2.  Structure-function relationships among wild-type variants of Staphylococcus aureus beta-lactamase: importance of amino acids 128 and 216.

Authors:  R K Voladri; M K Tummuru; D S Kernodle
Journal:  J Bacteriol       Date:  1996-12       Impact factor: 3.490

3.  Novel Insights into the Classification of Staphylococcal β-Lactamases in Relation to the Cefazolin Inoculum Effect.

Authors:  Lina P Carvajal; Sandra Rincon; Aura M Echeverri; Jessica Porras; Rafael Rios; Karen M Ordoñez; Carlos Seas; Sara I Gomez-Villegas; Lorena Diaz; Cesar A Arias; Jinnethe Reyes
Journal:  Antimicrob Agents Chemother       Date:  2020-04-21       Impact factor: 5.191

4.  Comparison of the beta-lactamase gene cluster in clonally distinct strains of Enterococcus faecalis.

Authors:  J F Tomayko; K K Zscheck; K V Singh; B E Murray
Journal:  Antimicrob Agents Chemother       Date:  1996-05       Impact factor: 5.191

5.  Cefazolin Inoculum Effect and Methicillin-Susceptible Staphylococcus aureus Osteoarticular Infections in Children.

Authors:  J Chase McNeil; Lauren M Sommer; Mary Boyle; Patrick Hogan; Jesus G Vallejo; Kristina G Hultén; Anthony R Flores; Sheldon L Kaplan; Stephanie Fritz
Journal:  Antimicrob Agents Chemother       Date:  2020-08-20       Impact factor: 5.191

6.  A Chemical Approach for Programmable Protein Outputs Based on Engineered Cell Interactions.

Authors:  Daniel A Jacome; Justin D Northrup; Andrew J Ruff; Sean W Reilly; Iris K Lee; Gabrielle S Blizard; Mark A Sellmyer
Journal:  ACS Chem Biol       Date:  2020-12-22       Impact factor: 5.100

7.  Real-time PCR assay for detection of blaZ genes in Staphylococcus aureus clinical isolates.

Authors:  Lynette A Pereira; Gerald B Harnett; Meredith M Hodge; Julia A Cattell; David J Speers
Journal:  J Clin Microbiol       Date:  2014-01-29       Impact factor: 5.948

8.  Determination of an inoculum effect with various cephalosporins among clinical isolates of methicillin-susceptible Staphylococcus aureus.

Authors:  Esteban C Nannini; Martin E Stryjewski; Kavindra V Singh; Tom H Rude; G Ralph Corey; Vance G Fowler; Barbara E Murray
Journal:  Antimicrob Agents Chemother       Date:  2010-03-08       Impact factor: 5.191

9.  Efficacy of prophylaxis with beta-lactams and beta-lactam-beta-lactamase inhibitor combinations against wound infection by methicillin-resistant and borderline-susceptible Staphylococcus aureus in a guinea pig model.

Authors:  D S Kernodle; A B Kaiser
Journal:  Antimicrob Agents Chemother       Date:  1993-04       Impact factor: 5.191

10.  Characterization of a chromosomal gene encoding type B beta-lactamase in phage group II isolates of Staphylococcus aureus.

Authors:  R K Voladri; D S Kernodle
Journal:  Antimicrob Agents Chemother       Date:  1998-12       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.